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Chickenpox (varicella) is caused by primary infection with varicella zoster virus (VZV), which can establish long-term latency 
in the host ganglion. Once reactivated, the virus can cause shingles (zoster) in the host. VZV has a typical herpesvirus virion 
structure consisting of an inner DNA core, a capsid, a tegument, and an outer envelope. The tegument is an amorphous layer 
enclosed between the nucleocapsid and the envelope, which contains a variety of proteins. However, the types and functions of 
VZV tegument proteins have not yet been completely determined. In this review, we describe the current knowledge on the 
multiple roles played by VZV tegument proteins during viral infection. Moreover, we discuss the VZV tegument pro-
tein-protein interactions and their impact on viral tissue tropism in SCID-hu mice. This will help us develop a better under-
standing of how the tegument proteins aid viral DNA replication, evasion of host immune response, and pathogenesis. 
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Varicella zoster virus (VZV), which belongs to the al-
phaherpesvirus subfamily of the Herpesviridae family, 
causes chickenpox (varicella) in children during primary 
infection and can establish long-term latency in the dorsal 
root ganglia (DRG) or cranial nerve sensory ganglia [1]. 
Subsequent reactivation of latent VZV may cause shingles 
(zoster) [1,2]. In addition, VZV infection may lead to seri-
ous complications such as encephalitis, meningitis, myelitis, 
conjunctivitis, and postherpetic neuralgia, which is most 
common. The latter condition is a painful, refractory disease 
that can seriously affect a patient’s quality of life [3–6]. 
VZV virions, like all the other herpesviruses, are composed 
of a DNA core, a capsid, a tegument, and an envelope (Fig-
ure 1). The innermost layer of these virions is a nucleocap-
sid containing the VZV DNA genome and the outermost 
layer is an envelope that is derived from the host cell mem-
branes and contains viral envelope glycoproteins. Between 
the nucleocapsid and envelope is an amorphous protein lay-
er known as the tegument. Herpesvirus tegument proteins 
have been shown to play a number of key roles during viral 
infection. These functions include the intracellular transport 
of virus particles [7–16], viral assembly, and egress [17–30], 
regulation of viral and host cell gene transcription and  
protein expression [31–43], as well as viral immune  
evasion [41,44–47].  
The VZV genome is a double-stranded DNA molecule, 
which is approximately 125 kb in length, containing at least 
70 open reading frames (ORFs) [1,48]. Although VZV has 
the smallest genome in the herpesvirus family, research on 
VZV protein functions and molecular mechanisms of VZV 
pathogenesis has lagged behind comparable research on 
other herpesviruses such as the herpes simplex virus-1 
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Figure 1  Electron micrograph of VZV. A, Extracellular VZV virion seen by TEM at a magnification of 30,000×. B, VZV virion structure. 
(HSV-1) and the pseudorabies virus (PRV). One issue in 
analyzing the types and relative amounts of VZV tegument 
proteins is the strong cell-associated nature of VZV, which 
makes it very difficult to obtain mature VZV virions in suf-
ficient quantity and purity for mass spectrometry analysis. 
Currently, both types and functions of VZV tegument pro-
teins are mainly predicted from their HSV-1 homologues, 
which have already been identified and relatively well 
characterized (Table 1). Recent advances in bacterial artifi-
cial chromosome (BAC) technology have made genetic 
manipulation of the VZV genome more efficient, which 
greatly facilitates studies on functions of VZV genes and 
their products, virus-host interactions in VZV pathogenesis, 
as well as the design and development of new antiviral 
strategies and novel vaccines against VZV [49–51]. Addi-
tionally, in vivo studies of VZV pathogenesis have been 
aided by the development and use of the SCID-hu mouse 
model, which helps to overcome the strict species specifici-
ty of VZV and the corresponding lack of appropriate animal 
models for this research [50,51]. Current studies have 
shown that VZV tegument proteins also play important 
roles in VZV infection. Here we review recent progress in 
functional characterization of VZV tegument proteins as 
well as insights into the mechanism of VZV pathogenesis 
gained from these studies.  
1  VZV immediate early (IE) protein within the 
tegument 
The VZV genome encodes for at least three IE proteins, 
namely, IE4 (encoded by orf4), IE62 (encoded by orf62 and 
orf71), and IE63 (encoded by orf63 and orf70). Orf62 and 
orf63 in the internal repeat region of the genome are dupli-
cated in the terminal repeat region as orf71 and orf70, re-
spectively [48]. VZV IE proteins IE4, IE62, and IE63 have 
all been identified as structural components of VZV virions 
and are likely located within the tegument layer according 
to protein content analysis of purified VZV virions [52,53]. 
In addition, VZV-encoded ORF61 protein is the functional 
homolog of HSV-1 IE protein ICP0, and thus, is a putative 
VZV IE protein. However, ORF61 is not virion-associated [52]. 
The interplay between IE proteins and other viral or cel-
lular factors during VZV infection implicates VZV IE pro-
teins as important regulators of viral and host gene tran-
scription and expression [54–59]. In addition, VZV IE pro-
teins are also involved in host immune evasion. For exam-
ple, IE62 is capable of modulating host innate immune sig-
naling by antagonizing activation of interferon response 
factor 3 (IRF3) [60]; IE63 can suppress the antiviral activity 
induced by interferon- (IFN-) via inhibition of phos-
phorylation of the  subunit of eukaryotic initiation factor 2 
(eIF-2) [61]. Thus, when VZV enters the cell, IE proteins 
in the tegument are presumed to be released into the cyto-
plasm along with the capsid and may be further transported 
into the nucleus. These proteins could then aid in host im-
mune suppression as well as activation of viral gene tran-
scription and expression, thereby promoting the efficient 
replication and cell-to-cell spread of VZV. 
In early studies of mechanisms underlying VZV latency 
and reactivation, IE proteins IE4, IE62, and IE63 were 
found to be expressed and show a predominantly cytoplas-
mic distribution in latently infected neurons [62–64]. In 
contrast, IE proteins, except IE4, are distributed mainly in 
the nucleus of cells during lytic VZV infection. Therefore, it 
is speculated that these IE proteins are sequestered from the 
nucleus during VZV latency, thereby limiting their role in 
gene transactivation and VZV replication [64]. Furthermore, 
IE4 and IE63 were also found to be essential for the estab-
lishment of VZV latency in a cotton rat model infected with 
VZV gene deletion mutants [65,66]. However, the role of 
VZV IE proteins expressed during latency remains elusive. 
VZV deletion mutants for orf4, orf62/orf71, and 
orf63/orf70 fail to replicate in cell culture in vitro, in human 
skin organ culture (SOC) ex vivo, and in SCID-hu skin 
xenografts in vivo, respectively. Thus, these genes appear 
essential for VZV propagation [57,58,67,68]. Moreover, at 
least one copy of the duplicated IE62 or IE63 genes is re-
quired for VZV replication [57,68]. However, IE62 gene 
expression at an ectopic site in the VZV genome of a dual 
orf62/orf71 deletion mutant permits viral replication in cell 
culture but fails to restore virus infectivity in human skin 
implants in SCID-hu mice. This indicates the existence of 
regulatory regions at the native site of orf62 and/or orf71,
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Table 1  VZV putative tegument proteins and their functionsa) 





Cell culture# Predicted functions* Identified functions 
ORF3 UL55 Dispensable Potential negative regulatory role in viral 
gene expression [31] 
Not determined 
ORF7ᶲ UL51 Dispensable Role in virion maturation and egress; role 
in cell-cell viral spread [25] 
Role in cell-cell viral spread [107] 
ORF8 UL50 Dispensable dUTPase dUTPase 
ORF9‡ UL49 Essential Role in viral protein synthesis and 
mRNA accumulation at early times of 
infection [37]; induces stabilization of 
microtulule [126]; potential role in virion 
envelopment and transcriptional regula-
tion [24,32] 
Role in virion nuclear egress and sec-
ondary envelopment [83,84] 
ORF10ᶲ UL48 Dispensable α-transinducing factor; role in transacti-
vation of immediate early gene expres-
sion [33,34]; role in virion maturation 
and egress [23] 
Role in transactivation of immediate 
early gene expression [85,86] 
ORF11‡ UL47 Dispensable Role in gene expression [35]; role in 
virion maturation and egress [28] 
RNA binding capacity; role in viral 
protein synthesis at early times of in-
fection [76] 
ORF12‡ UL46 Dispensable Role in gene expression [35]; role in 
activation of Akt signaling [36]; potential 
role in virion tegumentation [30] 
Role in activation of Akt signaling and 
regulation of cell cycle [90]; role in 
phosphorylation of ERK1/2 and inhibi-
tion of apoptosis [77] 
ORF17o UL41 Essential Host shutoff protein Host shutoff protein 
ORF21 UL37 Essential Inner tegument protein [9]; role in deliv-
ery of capsids to the nucleus [9]; role in 
virion maturation and egress [26]; role in 
activation of NF-κB signaling pathway [44]
Not determined 
ORF22 UL36 Essential Inner tegument protein [9]; role in deliv-
ery of capsids to the nucleus [9]; role in 
virion maturation and egress [27]; role in 
abrogation of IFN-β production [45] 
Not determined 
ORF36 UL23 Dispensable Thymidine kinase Thymidine kinase 
ORF38 UL21 Essential Roles in faciliating viral gene expression 
during early stages of infection [38]; 
possible role in capsid transport [13] 
Not determined 
ORF44 UL16 Essential Potential role in viral genome packaging 
and virion maturation [29] 
Role in the efficient production of 
infectious progeny virus [110] 
ORF46 UL14 Essential Minor tegument protein [9]; chapter-
one-like activity [127]; roles in virion 
maturation and egress [14] 
Not determined 
ORF47ᶲ UL13 Dispensable Serine/threonine kinase; role in immune 
evasion [47] 
Serine/threonine kinase; role in immune 
evasion [102] 
ORF49ᶲ UL11 Dispensable Myristylated and palmitylated virion 
protein; roles in virion envelopment and 
egress [22] 
Myristylated virion protein; role in the 
efficient production of infectious prog-
eny virus [110] 
ORF53 UL7 Essential Palmitylated virion protein; potential role 
in mitochondrial function [128] 
Not determined 
ORF61o ICP0 Essential Transactivator or repressor; E3 ubiquitin 
ligase activity; mutiple roles in immune 
evasion [41] 
Transactivator or repressor; E3 ubiqui-
tin ligase activity [129]; mutiple roles in 
immune evasion [130,131] 
ORF66ᶲ US3 Dispensable Inner tegument protein [9]; ser-
ine/threonine kinase; role in viral nuclear 
egress [19–21]; reorganizes the actin 
skeleton[132,133]; role in regulation of 
gene expression [42]; inhibits cell apopto-
sis [39,40]; role in immune evasion [46] 
Serine/threonine kinase; modulates host 
immune response through downregula-
tion of cell surface MHC-I [106] 
ORF62/71‡ ICP4 Essential Major transactivator; transcriptional re-
pressor of viral immediate early gene [43]
Major transactivator; transcriptional 
repressor of viral immediate early 
genes; role in prevention of IFN produc-
tion by inhibiting activation of IRF3 [60]
ORF64/69 US10 Dispensable Not determined Not determined 
a) *, Functions of VZV putative tegument proteins were predicted based on charateristics of their homologous counterparts in HSV-1. #, Functions in cell 
culture were determined using VZV mutants null for genes encoding putative tegument proteins. o, the protein is proved not virion-associated. ᶲ, the protein 
is proved virion-associated but its localization within the tegument of virion has not been confirmed. ‡, the protein is proved as a tegument protein in VZV.  
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which may affect the functions of adjacent genes [57]. In 
addition, it has been found that IE62 of parental Oka VZV 
(P-Oka) has stronger transactivation activity than that of the 
Oka vaccine strain (V-Oka), which is due to multiple muta-
tions within orf62 in the vaccine virus and may contribute to 
attenuation of V-Oka in skin [69–72]. Overall, the gene 
products of the major transactivator IE62, as well as its gene 
sequence and precise position in VZV genome play a pivot-
al role in VZV skin pathogenesis. In contrast, infectivity of 
a dual orf63/orf70 deletion mutant can be restored to that of 
the wild type in culture as well as in skin and thymus/liver 
(T cell) xenografts in SCID-hu mice by introducing one 
copy of orf63 into an ectopic site in the VZV genome [68]. 
Therefore, it is the gene product of orf63 rather than its gene 
sequence at the native site that performs functions in VZV 
pathogenesis. Further studies were carried out with the aim 
of identifying functional domains of IE63. It was demon-
strated that mutations of IE63 phosphorylation sites at ser-
ine 165 and 173 result in loss of VZV infectivity. On the 
other hand, a single alanine substitution at serine 181, serine 
185, or threonine 171, which are also phosphorylation sites 
of IE63, impairs VZV replication both in culture and in skin 
implants in SCID-hu mice but has no effect on viral infec-
tivity in T cells in vivo [73]. These data suggest that phos-
phorylation of IE63 by viral and/or cellular kinases is criti-
cal for VZV pathogenesis in skin, but the regulatory mech-
anism of IE63 phosphorylation and its function remain to be 
defined. 
2  A conserved gene cluster of VZV containing 
orf9 to orf12 
VZV orf9, orf10, orf11, and orf12 form a conserved gene 
cluster, which is located in the unique long region of the 
VZV genome [74]. Their homologous HSV-1 counterparts 
encode virus tegument proteins that are important for viral 
replication [75], and therefore proteins encoded by this gene 
cluster are putative VZV tegument proteins. To date, VZV 
ORF10 has been shown to be a component of the virus par-
ticle through western blot analysis of gradient-purified viri-
ons [53], while ORF9, ORF11, and ORF12 are detected in 
the tegument of virions using immunogold electron mi-
croscopy [74,76,77].  
Orf9, which encodes a viral structural protein, is one of 
the most abundantly transcribed genes during VZV infec-
tion [78,79], and is essential for VZV growth both in vitro 
and in vivo [67,74]. However, the homologue of VZV orf9 
in HSV-1 and PRV is dispensable for virus replica- 
tion [80,81]. Thus, it is likely that orf9 differs from its hom-
ologues in its function during viral infection. Currently, 
VZV ORF9 has been reported to have several functions. For 
instance, ORF9 is predicted to orchestrate the assembly of 
VZV virus particles by recruiting VZV tegument proteins, 
including IE62, IE4, IE63, and ORF47 which form a com-
plex with IE62 during viral infection, on the microtubule 
network [82]. ORF9 has also been shown to interact with 
VZV glycoprotein E (gE), which is not part of the 
ORF9-IE62-tubulin complex, but may be involved in sec-
ondary envelopment [74]. Lastly, ORF9 has been implicat-
ed in VZV formation and egress, and this appears to be me-
diated through VZV ORF47 kinase-dependent phosphoryla-
tion of ORF9 [83]. According to the latest report, deletion 
of the acidic cluster corresponding to amino acid (aa) 85 to 
93 of ORF9, which contains the ORF47 phosphorylation 
consensus sequence, disrupts interactions between ORF9 
and ORF47 as well as phosphorylation of ORF9. This dele-
tion also causes the nuclear accumulation of ORF9 and 
ORF47, and most importantly, results in accumulation of 
primary enveloped VZV capsids in the perinuclear space 
due to a de-envelopment defect [84]. Therefore, it seems 
that ORF9 also regulates virus nuclear egress. 
ORF10 is capable of transactivating the VZV IE62 pro-
moter and plays a significant role in the initiation of VZV 
infection [85,86]. Orf10 is not essential for VZV replication 
in culture and in T cells in vivo, but deletion of orf10 im-
pairs VZV replication in skin ex vivo and in vivo [67,87]. In 
addition, upstream stimulatory factor (USF), which is iden-
tified as a cellular transcription factor, binds specifically to 
the consensus sequence within the promoter region of orf10 
and is important for optimal transactivation activity of IE62. 
Deletion of the USF binding site in the orf10 promoter im-
pairs the virus infectivity in skin xenografts in SCID-hu 
mice, which is consistent with the phenotype of the 
full-length orf10 deletion mutant [88]. Therefore, USF is a 
cellular determinant of VZV virulence, which is required 
for VZV replication in human skin in vivo. In short, ORF10 
is involved in the regulation of viral and host gene expres-
sion, which is mediated by VZV IE62 and cellular USF, and 
is one of the determinants of VZV pathogenesis in skin in 
vivo.  
Like orf10, orf11 is not essential for VZV growth in cul-
ture, but deletion of orf11 impairs viral infectivity severely 
in SCID-hu skin xenografts. Therefore, VZV ORF11 is also 
a determinant of VZV virulence in skin [74]. Further studies 
have been carried out to investigate the exact function of 
ORF11 in VZV infection. ORF11 was identified as a RNA 
binding protein with a conserved RNA-binding domain. 
However, knockout of this RNA-binding site does not affect 
VZV virulence both in vitro and in vivo [76]. Recently, 
ORF11 has been characterized to interact with ORF9, and 
mutation of the ORF9 binding site in ORF11 impairs VZV 
virulence in skin in vivo as severely as the deletion of orf11 [89]. 
These data implicate that interactions between ORF11 and 
ORF9 play a key role in the function of ORF11 as a viru-
lence determinant of VZV skin pathogenesis.  
Orf12 is a non-essential gene for VZV growth both in 
vitro and in vivo [67,74], but ORF12 still contributes to op-
timal VZV infection. For example, ORF12 activates the 
PI3K/Akt/GSK-3 signaling pathway and thus regulates 
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host cell cycle progression [90]; ORF12 also activates 
ERK1/2 and p38 and inhibits apoptosis of the infected host 
cell [77]. In summary, orf9-12 gene cluster plays a crucial 
role in VZV replication. Orf9 is essential for VZV growth 
both in vitro and in vivo. Although orf10 and orf11 are dis-
pensable for VZV replication in culture, they are both es-
sential for VZV virulence in skin implants in SCID-hu mice. 
It is further demonstrated that USF binding to the orf10 
promoter and interactions between ORF9 and ORF11 are 
likely part of the mechanism underlying VZV pathogenesis 
in skin. On the other hand, ORF12, which is not essential 
for VZV replication, is able to activate certain cellular sig-
naling pathways and promote VZV infection. 
3  VZV serine/threonine kinases, ORF47 and 
ORF66 
The VZV genome encodes two types of serine/threonine 
kinases, ORF47 and ORF66 [91]. Both proteins are known 
to be virion-associated and are putative VZV tegument pro-
teins based on the characteristics of their homologues in the 
alphaherpesvirus subfamily [75,92,93]. Orf47 and orf66 are 
both dispensable for VZV growth in culture. However, the 
orf47 deletion mutant fails to replicate both in skin and in T 
cells in SCID-hu mice, while knockout of orf66 impairs 
VZV virulence in T cells but has almost no effect on viru-
lence in skin in vivo [94–96]. In addition, mutation of the 
kinase motif of ORF47 and ORF66 produces phenotypes 
that are similar to their full-length gene knockout  
mutants [97,98]. Therefore, kinase activities of ORF47 and 
ORF66 are likely to be responsible for VZV virulence and 
tissue tropism. 
To date, putative VZV tegument proteins ORF9, IE62, 
and IE63 are proven substrates of VZV ORF47 kin- 
ase [83,99]. As mentioned above, ORF47 binding and 
phosphorylation of ORF9 as well as IE63 is crucial for VZV 
replication [73,83,84]. On the other hand, although kinase 
activities of ORF47 are of great importance for VZV infec-
tion in vivo, protein-protein interactions and complex for-
mation between ORF47 and IE62 have been proven essen-
tial for VZV replication in human skin in vivo in a further 
study [97,100]. ORF47 also phosphorylates the viral enve-
lope protein gE [101]. When orf47 is deleted, endocytosed 
gE will be phosphorylated by a cellular kinase, casein ki-
nase II (CKII), lose its localization in the trans-Golgi net-
work (TGN) and recycle to the plasma membrane. This is 
likely the cause of increased cell-to-cell spread and larger 
syncytia formation observed in cells infected with the orf47 
knockout mutant. Further, ORF47 also helps VZV to evade 
host immune responses through inhibition of IRF3 activa-
tion [102]. 
ORF66 phosphorylates VZV major transactivator IE62, 
which results in nuclear export and cytoplasmic accumula-
tion of IE62 during late-stage VZV infection [103,104]. 
This is in contrast to ORF47-mediated IE62 phosphoryla-
tion, which does not affect IE62 nuclear localization [104]. 
Therefore, it is suggested that VZV ORF66 kinase can reg-
ulate IE62 nuclear functions by affecting IE62 subcellular 
localization. Both ORF66 and IE62 are expressed exclu-
sively in the cytoplasm of infected neurons during latency, 
and thus, ORF66-mediated cytoplasmic sequestration of 
IE62 is predicted as one mechanism that inhibits IE62 
transactivation activities and helps VZV stay dormant in 
neurons [105]. In addition, ORF66-mediated nuclear exclu-
sion of IE62 is also required for virion incorporation of 
IE62 [93]. Further, ORF66 plays a role in VZV immune 
evasion. ORF66 can affect the intracellular transport of ma-
jor histocompatibility complex class I (MHC-1) through the 
Golgi complex, leading to the downregulation of 
cell-surface MHC-1expression and thereby affecting viral 
antigen presentation [106]. 
4  ORF7, the first known determinant of VZV 
virulence in human neuronal cells 
ORF7 is a virion-associated protein and may be a part of 
the tegument given its homologue protein UL51 in  
HSV-1 [75,107]. Like the HSV-1 ul51 gene, orf7 is dispen-
sable for VZV growth in culture, however, ORF7 seems to 
affect VZV in vitro growth in a cell type-specific manner. 
For instance, deletion of orf7 has no effect on VZV growth 
in a human melanoma cell line MeWo. Conversely, orf7 
knockout mutant produces smaller plaque sizes and slower 
growth kinetics than wild-type virus in a human diploid 
retinal pigment epithelial (RPE) cell line ARPE-19, sug-
gesting defects in cell-to-cell spread [67,107]. Further, it is 
demonstrated that deletion of orf7 impairs VZV virulence in 
ex vivo human skin, and thus, ORF7 is recognized as one of 
the virulence factors required for VZV skin infection [67]. 
Meanwhile, the orf7 knockout mutant is severely impaired 
in its ability to grow in differentiated SH-SY5Y human 
neuroblastoma cells and normal human neuronal cells de-
rived from human embryonic stem cells (hESC) in vitro. 
The same is true in human DRG ex vivo and in vivo, in con-
trast to the robust infection by wild type virus. Therefore, 
orf7 is reported to be the first full-length gene responsible 
for VZV virulence in neuronal cells [107]. Subsequently, 
deletion of VZV orf7 was shown not to prevent axonal in-
fection and retrograde transport of virus particles to the 
neuronal somata in hESC-derived neurons in vitro [108]. 
However, viral and host gene transcription and protein ex-
pression have not yet been evaluated in these VZV-infected 
hESC-derived neuronal cells. Thus, it is unknown whether 
the orf7 knockout mutant remains latent or begins to repli-
cate and produce progeny viruses. In summary, although 
ORF7 has dual roles as virulence determinants in human 
skin and in DRG in vivo, the underlying mechanism has yet 
to be studied. 
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5  VZV ORF44 and ORF49 
ORF44 and ORF49 are both putative tegument proteins of 
VZV according to homology-based predictions [75]. How-
ever, only ORF49 has been shown to be a component of 
VZV virions [109]. Like orf7, orf49 is dispensable for VZV 
replication in vitro but has cell type-specific functions in 
cell-to-cell transmission of the virus. Deletion of orf49 im-
pairs viral spread in MeWo cells but not in a human em-
bryonic lung fibroblast diploid cell strain, MRC-5, in com-
parison to the growth of wild type virus in both cell types. 
Therefore, ORF49 is regarded as a cell-tropic factor of VZV 
in vitro but the underlying mechanism remains elusive [109]. 
Moreover, an orf49 knockout mutant also shows defective 
growth in SOC. Thus, it seems that ORF49 plays a signifi-
cant role in VZV pathogenesis in human skin [67]. On the 
other hand, orf44 appears to be essential for VZV replica-
tion, however, characteristics of ORF44 has not yet been 
reported [67]. 
Recently, ORF44 and ORF49 have been shown to inter-
act and form a complex [110]. The binding motifs of these 
two proteins have been identified to be a single phenylala-
nine residue at position 129 for ORF44 and four amino ac-
ids from positions 41–44 in the carboxyl-terminal half of 
ORF49. The interaction between ORF44 and ORF49 is re-
quired for VZV infection in vitro, and a substitution of 
phenylalanine for alanine at position 129 of ORF44 causes 
lethal defects in viral replication, which is consistent with 
the phenotype of an orf44 deletion mutant. Similarly, a 
VZV mutant with the aa 41–44 deletion shows defective 
viral growth in MeWo, which is comparable to that of an  
orf49 knockout virus. However, this ORF49 mutant has not 
been evaluated in the SCID-hu mouse model, and thus, the  
role of ORF44 and ORF49 interaction in VZV pathogenesis 
in vivo has yet to be elucidated. 
6  Other VZV tegument proteins of unknown 
function 
As with the proteins mentioned above, ORF3, ORF8, 
ORF17, ORF21, ORF22, ORF36, ORF38, ORF46, ORF53, 
and ORF64/69 are all putative VZV tegument proteins, 
among which only ORF17 is characterized as the virion 
host shut off (VHS) protein but it is not associated with 
VZV virions [75,111]. In a comprehensive study of VZV 
virulence in MeWo in vitro and in SOC ex vivo, ORF3, 
ORF8, ORF36, and ORF64/69 were shown to be dispensa-
ble, while ORF21, ORF22, ORF38, and ORF53 were shown 
to be essential for VZV infection [67]. Apart from this study, 
there have been few reports regarding these proteins and 
research on their roles in VZV infection is still lacking. 
However, it should be noted that their homologous coun-
terparts in HSV-1 have proved to be very important for viral 
replication and growth [9,13,14,26,27,31,38,44,45,127,128]. 
7  Conclusion and perspectives 
VZV tegument proteins, like those of other herpesviruses, 
play multiple important roles at different stages of VZV 
infection, including regulation of viral and host gene ex-
pression, modulation of host immune response, and viral 
assembly and egress (Table 1). VZV tegument proteins are 
involved in a complicated network of interactions [112,113]. 
Some VZV tegument proteins have proved to be determi-
nants of cell and tissue tropism and pathogenicity (Table 2). 
Table 2  Tegument proteins required for VZV virulence in human skin, T cells and DRG in vivo in SCID-hu mouse model as well as their identified func-
tional domains or motifsa) 
Protein Mutation description Skin* T cells* DRG*  
ORF7 Deletion × O‡ ×  
ORF10 Deletion × O –  
 Mutation of USF binding site × – –  
ORF11 Deletion × – –  
 Mutation of ORF9 binding site × – –  
ORF47 Deletion × × –  
 Mutation of kinase motif × × –  
ORF49 Deletion × – –  
ORF66 Deletion O × –  
 Mutation of kinase motif O × –  
ORF62/ORF71 Deletion of the duplicate genes with ectopic IE62 expression × – –  
ORF63/ORF70 Mutation of phosphorylation sites S181, S185 or T171 × O –  
a) *, Determinants of VZV virulence in human tissues were screened out using recombinant VZV variants and the SCID-hu mouse model. ‡, Un-
published data from our lab. ×, no replication or impaired replication. O, no effect. –, not determined. 
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Nonetheless, only about half of these proteins have been 
studied to date, and great efforts are still required to charac-
terize the functions of these proteins to improve our under-
standing of VZV pathogenesis.  
VZV is highly homologous to HSV-1. Given this, the 
functions of VZV tegument proteins can be studied with 
particular reference to the research methods and experi-
mental design for functional characterization of their HSV-1 
counterparts. For example, the hESC-derived neuron model, 
together with time-lapse fluorescence microscopy, can be 
used to study the function of VZV tegument proteins in ax-
onal infection and transport of virus particles. Similar sys-
tems have been widely used for functional studies of HSV-1 
and PRV tegument proteins [8,15,16]. However, as men-
tioned above, only tegument protein ORF7 of VZV has 
been evaluated in this system [108]. Unlike HSV-1, VZV is 
highly cell-associated in cell culture and is highly spe-
cies-specific so that research methods involving VZV have 
to be properly designed and executed to match its own 
characteristics. For example, in recent years, there has been 
concern about how tegument proteins become incorporated 
into the virion of herpesviruses. Although sufficient virions 
with high purity can be obtained and protein content in the 
tegument has been clarified in studies of HSV-1, the struc-
ture of the tegument appears amorphous using transmission 
electron microscopy (TEM) and cannot be determined at 
high resolution using cryo-electron tomography (cryo-ET) 
and cryo-electron microscopy (cryo-EM) due to the lack of 
radial symmetry [114–118]. However, accumulating evi-
dence suggests that tegument proteins are incorporated into 
the virion orderly during assembly [18,119–124]. In addi-
tion, it is found that inner tegument proteins of HSV-1 and 
PRV recruit microtubule motors onto viral capsids and fa-
cilitate intracellular transport of virus particles [9,11]. As 
for VZV, it is very difficult to purify large numbers of ma-
ture infectious virus particles for these studies due to its 
cell-associated nature. Therefore, the structure and protein 
composition of the VZV tegument as well as the interac-
tions between the virus particle and the host cell remain to 
be investigated. 
Currently, the combination of VZV BAC technology and 
the SCID-hu mouse model has significantly advanced our 
understanding of VZV pathogenesis in vivo. Due to the rel-
atively high availability of fetal human skin and the sim-
plicity of its subcutaneous transplantation, functions of 
VZV genes and their products are studied more comprehen-
sively in skin xenografts in SCID-hu mice. In contrast, the 
availability of fetal thymus and liver and DRG tissue is lim-
ited, and it is difficult to transplant these tissues under the 
kidney capsule in SCID-hu mice. Thus, the SCID-hu mouse 
model with thymus/liver or DRG xenografts has not been 
used as widely as that with skin xenografts in VZV studies. 
Moreover, human skin can be used for VZV infection by 
almost 10 days post-transplant in SCID-hu mice. In contrast, 
DRG can be used for infection at nearly one month after 
transplantation, while it takes at least 3 months before thy-
mus/liver (T cells) xenograft can be used for VZV inocula-
tion. So far, among VZV tegument proteins, only the two 
viral kinases, ORF47 and ORF66, have been shown to af-
fect VZV T-cell tropism, while ORF7 is the first determi-
nant of VZV virulence reported to affect viral neuroninva-
sion [94,107]. Thus, the function of many tegument proteins 
in VZV infection of T cells and neuronal cells remains to be 
determined. 
Given that VZV tegument proteins are critical for VZV 
infection, they represent potential targets for VZV antiviral 
therapy. Although some of VZV tegument proteins are dis-
pensable in culture, they are determinants of VZV tissue 
tropism and virulence in vivo. For example, deletion of 
VZV tegument ORF7 can impair viral virulence both in 
human skin and neurons, which may disrupt the ability of 
the virus to cause chickenpox and herpes zoster [67,107]. 
The current VZV vaccine is a live attenuated viral vaccine 
whose administration is generally regarded as safe [125]. 
However, the mechanism underlying attenuation of this 
vaccine virus remains unclear. Therefore, deletion of viru-
lence determinants in VZV may generate a safer live vac-
cine candidate, which may have a significant impact on 
human lives and public health.  
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